Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1192 of 6351
-
Scientists probe immune system secrets behind vaccines that protect for decades
Knowledge-focused Recruiting nowThe ability of the vaccines today to generate a long-lasting protection against infections varies greatly from one vaccine to another. The yellow fever vaccine (YF-17D) is one of the most successful vaccines ever developed, having been administered to over 600 million people glob…
Phase 4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Blood test could predict esophageal cancer return
Knowledge-focused Recruiting nowPurpose of this study is to determine the value of liquid biopsies, e.g. testing of minimal residual disease (MRD) by using liquid biopsies to measure circulating tumour DNA (ctDNA) at diagnosis and during the multimodal and multidisciplinary curative-intent treatment of resectab…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Strawberry compound could help breast cancer survivors walk farther
Symptom relief Recruiting nowThis phase II trial tests whether fisetin works to improve physical function in women who have received chemotherapy for stage I-III breast cancer treatment. Fisetin is a naturally occurring substance that is found in strawberries and other foods. Fisetin eliminates cells that ha…
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New contrast mammogram may spot more cancers in dense breasts
Diagnosis Recruiting nowThe over-arching goal of the Contrast-Enhanced Spectral Mammography Imaging Screening Trial (CMIST) is to determine if dual-energy contrast-enhanced spectral mammography (CESM) can detect more cancers with fewer false positives than digital breast tomosynthesis (DBT) in women wit…
Sponsor: American College of Radiology • Aim: Diagnosis
Last updated Aug 02, 2026 00:00 UTC
-
Ancient herbal mix put to the test against psoriasis
Disease control CompletedPsoriasis is an inflammatory skin disease with huge negative impact on the quality of life of the patients, and has an overall prevalence of 2% to 3% in the general population. Plaques psoriasis is the most common type of the disease and presents red, well demarcated, and silvery…
Phase 2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New magnetic heart test could speed up heart attack diagnosis in ER
Diagnosis By invitation onlyThe purpose of the research is to see if patients that come to the Emergency Department with chest pain can be more accurately and more quickly diagnosed by magnetocardiography (MCG) to see if their chest pain is caused by coronary ischemia (reduced blood flow to the heart) in pa…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Empowerment, not just education, may boost breast cancer screening in latinas
Prevention OngoingThe design builds on past studies by integrating social network analysis (SNA) and implementation science (IS) into a longitudinal randomized clinical trial (RCT). The investigator will compare the long-term effects of interventions by examining guideline-concordant initial and r…
Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Aug 22, 2026 00:00 UTC
-
Shock wave therapy takes on vacuum wound care for stubborn diabetic foot ulcers
Disease control CompletedThis study will be a randomized, open-label, pretest post-test with two study groups.
Sponsor: Cairo University • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New HIV strategy aims to help people who inject drugs in india
Disease control CompletedThe goal of this study is to improve HIV care outcomes for people who inject drugs (PWID) in India. The study will implement a two-phase trial to evaluate whether HIV treatment outcomes (HIV viral suppression) in HIV infected PWID can be improved with three different intervention…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Can a new nucleotide analogue boost cancer treatment?
Disease control Stopped earlyThis study is an open-label, multi-arm, parallel cohort, dose validation and expansion design. The study is modular in design, allowing evaluation of the safety, efficacy and pharmacokinetics (PK) of NUC-3373 in combination with other agents for the treatment of patients with dif…
Phase 1/2 • Sponsor: NuCana plc • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Poop pills plus immunotherapy: new hope for stubborn cancers?
Disease control Recruiting nowThis is a single-center, open-label, Phase 2 study to evaluate the efficacy and safety of FMT with nivolumab in patients with advanced, unresectable, or metastatic solid cancer who have progressed during anti-PD-(L)1 therapy.
Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Blood filtering may heal rare skin wounds in kidney patients
Disease control Recruiting nowThe investigators propose to set up a prospective randomized controlled trial to control the security and assess the efficacy of adjuvant treatment by rheopheresis in necrotizing-ulcered calciphylaxis in the hemodialysis population.
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can a synthetic cannabinoid calm agitation in frontotemporal dementia?
Symptom relief Stopped earlyThe primary goal of this study is to test the hypothesis that oral nabilone treatment will reduce agitation compared with placebo in patients with Frontotemporal Dementia (both behavioural variant frontotemporal dementia and primary progressive aphasia). The study population is d…
Phase 2 • Sponsor: Simon Ducharme, MD • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Brain filter may prevent stroke during heart procedure
Disease control Recruiting nowThe purpose of the study is to see if the Sentinel® Cerebral Protection System may prevent occurrence of stroke during an ablation procedure for atrial fibrillation (AF). The secondary purpose of this study is to study if cognitive function after AF ablation differs between those…
Sponsor: Malini Madhavan • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Brain tumor genetics revealed by noninvasive scan
Knowledge-focused Recruiting nowIn France, about 5000 new people with a primary malignant brain tumor are diagnosed each year. The most common primary tumors are gliomas, originating from glial cells (astrocytomas and oligodendrogliomas). Low-grade gliomas are mildly aggressive, but they often evolve into a mor…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Can a simple repellent shield kids from mosquito viruses?
Prevention CompletedThe primary objective of the study is to demonstrate and quantify the protective efficacy (PE) of a single SR product, in reducing DENV infection and active Aedes-borne virus (ABV) disease in human cohorts. The study design will be a prospective, cluster randomized controlled tri…
Sponsor: University of Notre Dame • Aim: Prevention
Last updated Jun 26, 2026 17:11 UTC
-
Could a cheaper copy of keytruda work just as well against cancer?
Disease control CompletedThe goal of this double-blind, randomized study is to establish the equivalence of pharmacokinetic properties, as well as the comparability of safety, immunogenicity and pharmacodynamics of the drug RPH-075 (international nonproprietary name (INN) is pembrolizumab) in comparison …
Phase 1 • Sponsor: R-Pharm • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can big data unlock the secrets of plasma cell cancers?
Knowledge-focused Recruiting nowThe goal of this multicenter observational study is to better understand the clinical and molecular characteristics, disease progression, treatment response, and clinical outcomes of patients with plasma cell dyscrasias, including monoclonal gammopathy of undetermined significanc…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Booster battle: moderna vs. novavax for fourth COVID shot
Vaccine OngoingThis is a double-blinded, randomised study to determine the safety, reactogenicity, and immunogenicity of a bivalent mRNA Moderna COVID-19 vaccine or a protein-based Novavax COVID-19 vaccine given as a fourth dose in healthy adults in Australia.
Phase 3 • Sponsor: Murdoch Childrens Research Institute • Aim: Vaccine
Last updated Jun 27, 2026 08:08 UTC
-
Gene therapy trial aims to halt blindness in dry AMD
Disease control OngoingThis is a Phase 1/2 Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration (AMD). This is a multicenter study, which will be conducted in two phases and will enroll up to a total of 60 subjects.
Phase 1/2 • Sponsor: Ocugen • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC